Fresh cases remain below 1 lakh in India

NEW DELHI: JUNE 10 – In the last 24 hours, has reported 94,052 COVID-19 cases, and 6,148 deaths in the last 24 hours in India. This is the highest number of deaths that the country has seen in a day since the start of the pandemic. The jump in deaths come after Bihar revised its toll on Wednesday, adding 3,951 previously uncounted deaths to its tally.

Bharat Biotech on Wednesday said that the full data of phase III trials for Covaxin will be made public in July, ANI reported. The data will be first submitted to the Central Drugs Standard Control Organisation, followed by peer-reviewed journals with a timeline of three months for publication. Bharat Biotech told ANI once the final analysis of the phase III data is available, it would apply for a full licensure for Covaxin.

Bharat Biotech had earlier said that Covaxin has demonstrated overall interim clinical efficacy of 78 per cent, and 100 per cent efficacy against severe COVID-19 disease in phase III trials. The interim analysis was based on more than 87 symptomatic cases of COVID-19.

Meanwhile, Prime Minister Narendra Modi’s plan to provide free vaccines to states for all citizens over 18 years from June 21 is likely to cost the exchequer an additional Rs 15,000 crore compared with the Budget allocation of Rs 35,000 crore. “It is too early to give a correct estimate with multiple suppliers and different prices. But the rough estimate is total expenditure for vaccines for this year may be Rs 45,000-50,000 crore. -From The Indian Express